Evidence map›Paper›PMID 32542492›Full record

ArticleDer Internist2020

[Syncope].

W von Scheidt, T Klingenheben, R Bosch

Abstract read
PubMed Publisher
In one paragraph

Article in Der Internist, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

W von ScheidtI. Medizinische Klinik, Herzzentrum Augsburg-Schwaben, Universitätsklinikum Augsburg, Stenglinstr. 2, 86156, Augsburg, Deutschland. wolfgang.scheidt@uk-augsburg.de.
T KlingenhebenPraxis für Kardiologie Bonn und Ambulante Herzkatheter-Kooperation Bonn, Bonn, Deutschland.
R BoschCardio Centrum Ludwigsburg-Bietigheim, Ludwigsburg, Deutschland.
Klinikum Ludwigsburg · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Syncope is a frequent disorder, sometimes due to life-threatening causes. The uncertainty in its diagnosis requires a standardized approach. According to the 2018 European Society of Cardiology (ESC) guidelines, new aspects in evaluation and treatment include risk stratification and decision-making strategies during the initial evaluation in the emergency department, a reconsideration of diagnostic tests, algorithms for the treatment of reflex syncope, indications for an implantable cardioverter/defibrillator in high risk patients for sudden cardiac death, and organizational aspects such as interdisciplinary syncope units. The 2018 ESC guideline and the 2019 commentaries of the German Society of Cardiology (DGK) are an excellent and comprehensive instruction for safe, effective and efficient evaluation and therapy. However, some aspects require critical appraisal. The inadequate availability and reimbursement of pivotal diagnostic tests, such as tilt table testing and the implantable loop recorder is emphasized.

Indexed as

Defibrillators, ImplantablePractice Guidelines as TopicCardiac Pacing, ArtificialCardiologyGermanyHumansPhysical ExaminationSocieties, MedicalSyncopeTilt-Table TestCarotid sinus massageImplantable loop recorderRisk stratificationSyncope, vasovagalTilt table test

Identifiers

PMID32542492
OpenAlexW4250591598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.